52 studies found for:    "gene therapy" OR "gene transfer" OR "virus delivery" | Infection
Show Display Options
Rank Status Study
1 Unknown  Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
2 Recruiting Long-Term Follow-Up of Recipient of Gene Transfer Research
Conditions: Retroviridae Infections;   Cancer
Interventions: Other: Blood Tests;   Behavioral: Questionnaires
3 Completed Twins Study of Gene Therapy for HIV Infection
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   Kaposi's Sarcoma
Intervention: Drug: Syngeneic Lymphocytes (CD4+) Cultured with OKT3 (Ortho) and Interleukin-2 (Chiro
4 Terminated Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
Conditions: HIV Infections;   Pregnancy
Intervention:
5 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
6 Terminated Gene Transfer for HIV Using Autologous T Cells
Condition: HIV-1 Infection
Intervention: Genetic: pHIV7-shI-TAR-CCR5RZ treated CD4 cells
7 Active, not recruiting Safety and Efficacy of T Cell Genetic Immunotherapy for HIV
Condition: HIV Infection
Intervention: Genetic: VRX496-Modified Autologous T cells
8 Completed Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   HIV Infections
Intervention: Drug: Peripheral blood stem cells
9 Active, not recruiting Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: Busulfan;   Biological: Cal-1 modified HSPC;   Biological: Cal-1 modified CD4+ T lymphocytes
10 Completed An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection
Condition: HIV-1
Interventions: Other: Placebo;   Genetic: OZ1;   Genetic: CD34+ cells
11 Completed Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
Conditions: Chronic Granulomatous Disease;   Communicable Disease
Interventions: Drug: Gene Therapy Method for CGD;   Device: Isolex 300i Magnetic Cell Selector
12 Suspended Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT
Conditions: Haematological Malignancies;   CMV Infection
Intervention: Genetic: CMV-TCR transduced donor-derived T cells
13 Completed Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
Condition: Epstein-Barr Virus Infections
Intervention: Biological: Intravenous injection of EBV specific CTLS
14 Terminated Mecillinam for Treatment of Genital Chlamydia Infection
Conditions: Chlamydia Trachomatis Infection;   Chlamydial Urethritis
Intervention: Drug: Pivmecillinamhydrochlorid
15 Active, not recruiting Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Condition: HIV-1
Intervention: Genetic: OZ1 transduced cells
16 Recruiting Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
Conditions: AIDS-related Non-Hodgkin Lymphoma;   AIDS-related Plasmablastic Lymphoma;   AIDS-related Primary Effusion Lymphoma;   HIV Infection
Interventions: Drug: busulfan;   Biological: lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Completed Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection
Intervention: Drug: Interleukin-2
18 Completed Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer
Conditions: Hematologic Neoplasm;   HIV Infection
Intervention: Drug: GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV
19 Completed Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Condition: Epstein-Barr Virus Infections
Intervention: Biological: EBV specific T cells
20 Enrolling by invitation Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
Conditions: HIV-1 Infection;   Receipt of Cal-1 Modified Hematopoietic Cellular Products
Intervention: Genetic: Blood tests

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.